Institutional members access full text with Ovid®

Share this article on:


Silberstein, Stephen D.; Young, William B.

CONTINUUM: Lifelong Learning in Neurology: December 2006 - Volume 12 - Issue 6, Headache - p 106-132
doi: 10.1212/01.CON.0000290526.92944.b4

The treatment of migraine may be acute (abortive) or preventive (prophylactic). Preventive therapy is used in an attempt to reduce the frequency, duration, or severity of attacks. Additional benefits include enhancing the response to acute treatments, improving a patient's ability to function, and reducing disability. The major medication groups for preventive migraine treatments include anticonvulsants, antidepressants, ß-adrenergic blockers, calcium channel antagonists, serotonin antagonists, botulinum neurotoxins, nonsteroidal anti-inflammatory drugs, and others (including riboflavin, magnesium, and petasides). If preventive medication is indicated, the agent should be chosen from one of the first-line categories, based on the drug's relative efficacy in double-blind, placebo-controlled trials, its side effect profile, and the patient's preference, as well as coexistent and comorbid conditions.

© 2006 American Academy of Neurology
You currently do not have access to this article

To access this article:

Note: If your society membership provides full-access, you may need to login on your society website